Clinical efficacy and safety of Guipi decoction combined with escitalopram oxalate tablets in patients with depression

被引:2
|
作者
Yu, Jia [1 ]
Xu, Feng-Quan [2 ,3 ]
机构
[1] Beijing Changping Hosp Tradit & Western Med, Psychiat Dept, Beijing 102206, Peoples R China
[2] Chinese Acad Tradit Chinese Med, Guanganmen Hosp, Dept Psychosomat Med, Beijing 100053, Peoples R China
[3] Chinese Acad Tradit Chinese Med, Guanganmen Hosp, Dept Psychosomat Med, 5 Beixiange, Beijing 100053, Peoples R China
关键词
Jiajian Guipi decoction; Escitalopram oxalate tablets; Depressive disorder; Sleep quality; Traditional Chinese medicine syndromes; PREVALENCE; DISORDERS; THERAPY;
D O I
10.12998/wjcc.v11.i29.7017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUNDDepression is a widespread mental health condition that requires effective treatment. In the treatment of depression, traditional Chinese medicine (TCM) offers obvious advantages, fewer adverse reactions, and a lower recurrence rate. AIMTo evaluate the clinical benefits of Guipi decoction combined with escitalopram oxalate tablets for individuals with depression. METHODSIn total, 80 patients diagnosed as having depression were enrolled in the study and divided into either an experimental group or a control group. All of the patients were orally administered escitalopram oxalate tablets. Additionally, the experimental group received Jiajian Guipi decoction and reduced Governor vessel fumigation over 4 wk. TCM syndrome scores, Hamilton depression rating scale (HAM-D) scores, self-rating depression scale (SDS) scores, and Pittsburgh sleep quality index scores were measured for the two groups and compared before and after the treatment. The two groups were monitored for any adverse reactions. RESULTSAfter 4 wk of treatment, both groups exhibited a significant reduction in TCM syndrome scores compared with their pre-treatment scores (P < 0.05). However, the experimental group exhibited significantly lower TCM syndrome scores than the control group (P < 0.05). Similarly, the post-treatment SDS and HAM-D-24 scores were significantly lower in both groups than the pre-treatment scores (P < 0.05), with the experimental group exhibiting lower scores than the control group (P < 0.05). The total treatment efficiency was significantly better in the experimental group (97.14%) than in the control group (77.78%) (P < 0.05). Furthermore, after 4 wk of treatment, the Pittsburgh sleep quality index scores for both groups were significantly lower than those before the treatment (P < 0.05), with the experimental group exhibiting lower scores than the control group (P < 0.05). The incidence of adverse reactions was significantly lower in the experimental group than in the control group (P < 0.05). CONCLUSIONThe combination of Guipi decoction and escitalopram oxalate tablets was found to be an effective and safe treatment for depression. This combination could reduce TCM syndrome scores, improve depressive symptoms, and enhance sleep quality.
引用
收藏
页码:7017 / 7025
页数:9
相关论文
共 50 条
  • [1] Efficacy of escitalopram oxalate for patients with post-stroke depression
    Xu, Ji-hua
    Jiang, Peng
    MEDICINE, 2018, 97 (14)
  • [2] The therapeutic effects and safety of bright light therapy combined with escitalopram oxalate on insomnia in patients with poststroke depression
    Xiao, Meijuan
    Feng, Liang
    Wang, Qiongzhang
    Luan, Xiaoqian
    Chen, Siyan
    He, Jincai
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2021, 36 (01) : 182 - 189
  • [3] Simultaneous HPTLC Determination of Escitalopram Oxalate and Clonazepam in Combined Tablets
    Nilesh Dhavale
    Santosh Gandhi
    Shweta Sabnis
    Kailash Bothara
    Chromatographia, 2008, 67 : 487 - 490
  • [4] Simultaneous HPTLC determination of escitalopram oxalate and clonazepam in combined tablets
    Dhavale, Nilesh
    Gandhi, Santosh
    Sabnis, Shweta
    Bothara, Kailash
    CHROMATOGRAPHIA, 2008, 67 (5-6) : 487 - 490
  • [5] Efficacy and safety of escitalopram in patients with depression or anxiety or comorbid depression and anxiety
    Laux, G.
    Haerter, M.
    Fluerenbrock, W.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 192 - 192
  • [6] Efficacy and safety of escitalopram in patients with depression or anxiety or comorbid depression and anxiety
    Fluerenbrock, W.
    Haerter, M.
    Laux, G.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 191 - 191
  • [7] Clinical efficacy and safety of flunarizine tablets combined with betahistine hydrochloride tablets in patients with vertebrobasilar insufficiency vertigo
    Meng, Shanshan
    Liu, Qin
    Zhang, Liang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (11): : 8183 - 8190
  • [8] Efficacy of mirtazapine combined with escitalopram in the treatment of sleep disorders in patients with depression
    Xie, Sisi
    Liu, Yong
    MINERVA SURGERY, 2022,
  • [9] Efficacy of mirtazapine combined with escitalopram in the treatment of sleep disorders in patients with depression
    Xie, Sisi
    Liu, Yong
    MINERVA SURGERY, 2024, 79 (02): : 241 - 243
  • [10] Efficacy of escitalopram in patients with severe depression
    Azorin, JM
    Llorca, PM
    Despiege, N
    Verpillat, P
    EUROPEAN PSYCHIATRY, 2004, 19 : 217S - 217S